Cargando…
Recombinant human interferon-α1b inhibits SARS-CoV-2 better than interferon-α2b in vitro
• A comprehensive evaluation method for anti-SARS-CoV-2 drugs was established based on qPCR, TCID(50), and immunofluorescence. • A significant antiviral effect of rHuIFN-α1b was shown in Vero and Calu-3 cells. • rHuIFN-α1b has a good potential in the application of anti-COVID-19 therapy.
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wuhan Institute of Virology, Chinese Academy of Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786678/ https://www.ncbi.nlm.nih.gov/pubmed/35597770 http://dx.doi.org/10.1016/j.virs.2022.01.031 |
_version_ | 1784639166838996992 |
---|---|
author | Shi, Danrong Chen, Keda Lu, Xiangyun Cheng, Linfang Weng, Tianhao Liu, Fumin Wu, Nanping Li, Lanjuan Yao, Hangping |
author_facet | Shi, Danrong Chen, Keda Lu, Xiangyun Cheng, Linfang Weng, Tianhao Liu, Fumin Wu, Nanping Li, Lanjuan Yao, Hangping |
author_sort | Shi, Danrong |
collection | PubMed |
description | • A comprehensive evaluation method for anti-SARS-CoV-2 drugs was established based on qPCR, TCID(50), and immunofluorescence. • A significant antiviral effect of rHuIFN-α1b was shown in Vero and Calu-3 cells. • rHuIFN-α1b has a good potential in the application of anti-COVID-19 therapy. |
format | Online Article Text |
id | pubmed-8786678 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Wuhan Institute of Virology, Chinese Academy of Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-87866782022-01-25 Recombinant human interferon-α1b inhibits SARS-CoV-2 better than interferon-α2b in vitro Shi, Danrong Chen, Keda Lu, Xiangyun Cheng, Linfang Weng, Tianhao Liu, Fumin Wu, Nanping Li, Lanjuan Yao, Hangping Virol Sin Letter • A comprehensive evaluation method for anti-SARS-CoV-2 drugs was established based on qPCR, TCID(50), and immunofluorescence. • A significant antiviral effect of rHuIFN-α1b was shown in Vero and Calu-3 cells. • rHuIFN-α1b has a good potential in the application of anti-COVID-19 therapy. Wuhan Institute of Virology, Chinese Academy of Sciences 2022-01-25 /pmc/articles/PMC8786678/ /pubmed/35597770 http://dx.doi.org/10.1016/j.virs.2022.01.031 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Letter Shi, Danrong Chen, Keda Lu, Xiangyun Cheng, Linfang Weng, Tianhao Liu, Fumin Wu, Nanping Li, Lanjuan Yao, Hangping Recombinant human interferon-α1b inhibits SARS-CoV-2 better than interferon-α2b in vitro |
title | Recombinant human interferon-α1b inhibits SARS-CoV-2 better than interferon-α2b in vitro |
title_full | Recombinant human interferon-α1b inhibits SARS-CoV-2 better than interferon-α2b in vitro |
title_fullStr | Recombinant human interferon-α1b inhibits SARS-CoV-2 better than interferon-α2b in vitro |
title_full_unstemmed | Recombinant human interferon-α1b inhibits SARS-CoV-2 better than interferon-α2b in vitro |
title_short | Recombinant human interferon-α1b inhibits SARS-CoV-2 better than interferon-α2b in vitro |
title_sort | recombinant human interferon-α1b inhibits sars-cov-2 better than interferon-α2b in vitro |
topic | Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786678/ https://www.ncbi.nlm.nih.gov/pubmed/35597770 http://dx.doi.org/10.1016/j.virs.2022.01.031 |
work_keys_str_mv | AT shidanrong recombinanthumaninterferona1binhibitssarscov2betterthaninterferona2binvitro AT chenkeda recombinanthumaninterferona1binhibitssarscov2betterthaninterferona2binvitro AT luxiangyun recombinanthumaninterferona1binhibitssarscov2betterthaninterferona2binvitro AT chenglinfang recombinanthumaninterferona1binhibitssarscov2betterthaninterferona2binvitro AT wengtianhao recombinanthumaninterferona1binhibitssarscov2betterthaninterferona2binvitro AT liufumin recombinanthumaninterferona1binhibitssarscov2betterthaninterferona2binvitro AT wunanping recombinanthumaninterferona1binhibitssarscov2betterthaninterferona2binvitro AT lilanjuan recombinanthumaninterferona1binhibitssarscov2betterthaninterferona2binvitro AT yaohangping recombinanthumaninterferona1binhibitssarscov2betterthaninterferona2binvitro |